Apparatus and method for monitoring and controlling a peritoneal dialysis therapy

Information

  • Patent Grant
  • 10322224
  • Patent Number
    10,322,224
  • Date Filed
    Thursday, September 29, 2016
    7 years ago
  • Date Issued
    Tuesday, June 18, 2019
    5 years ago
Abstract
An apparatus for performing peritoneal dialysis includes a housing; a peritoneal dialysis supply bag supported by and/or located above the housing; a first valve for controlling gravity flow of fresh peritoneal dialysis fluid from the supply bag to a patient; a second valve for controlling gravity flow of used peritoneal dialysis fluid from the patient to a drain; and a pressure sensor positioned and arranged with respect to the gravity flow of fresh peritoneal dialysis fluid or the gravity flow of used peritoneal dialysis fluid to provide a reading used to evaluate a head height pressure.
Description
BACKGROUND

The present invention relates generally to the treatment of end stage renal disease. More specifically, the present invention relates to methods and apparatuses for monitoring the performance of peritoneal dialysis.


Using dialysis to support a patient whose renal function has decreased to the point where the kidneys no longer sufficiently function is known. Two principal dialysis methods are utilized: hemodialysis; and peritoneal dialysis.


In hemodialysis, the patient's blood is passed through an artificial kidney dialysis machine. A membrane in the machine acts as an artificial kidney for cleansing the blood. Because it is an extracorporeal treatment that requires special machinery, certain inherent disadvantages exist with hemodialysis.


To overcome the disadvantages associated with hemodialysis, peritoneal dialysis was developed. Peritoneal dialysis utilizes the patient's own peritoneum as a semi-permeable membrane. The peritoneum is a membranous lining of the abdominal body cavity. Due to good perfusion; the peritoneum is capable of acting as a natural semi-permeable membrane.


Peritoneal dialysis periodically infuses sterile aqueous solution into the peritoneal cavity. This solution is called peritoneal dialysis solution, or dialysate. Diffusion and osmosis exchanges take place between the solution and the blood stream across the natural body membranes. These exchanges remove the waste products that the kidneys normally excrete. The waste products typically consist of solutes like urea and creatinine. The kidneys also maintain the levels of other substances such as sodium and water which need to be regulated by dialysis. The diffusion of water and solutes across the peritoneal membrane during dialysis is called ultrafiltration.


In continuous ambulatory peritoneal dialysis, a dialysis solution is introduced into the peritoneal cavity utilizing a catheter. An exchange of solutes between the dialysate and the blood is achieved by diffusion. Further removal is achieved by providing a suitable osmotic gradient from the blood to the dialysate to permit water outflow from the blood. This allows a proper acid-base, electrolyte and fluid balance to be achieved in the body. The dialysis solution is simply drained from the body cavity through the catheter.


Peritoneal dialysis raises a number of concerns including: the danger of peritonitis; a lower efficiency and therefore increased duration of dialysis hours compared to hemodialysis; and costs incurred when automated equipment is utilized.


A number of variations on peritoneal dialysis have been explored. One such variation is automated peritoneal dialysis (“APD”). APD uses a machine, called a cycler, to automatically infuse, dwell, and drain peritoneal dialysis solution to and from the patient's peritoneal cavity. APD is particularly attractive to a peritoneal dialysis patient, because it can be performed at night while the patient is asleep. This frees the patient from the day-to-day demands of continuous ambulatory peritoneal dialysis during his/her waking and working hours.


The APD sequence typically lasts for several hours. It often begins with an initial drain cycle to empty the peritoneal cavity of spent dialysate. The APD sequence then proceeds through a succession of fill, dwell, and drain phases that follow one after the other. Each fill/dwell/drain sequence is called a cycle. APD can be and is practiced in a number of different ways.


Current APD systems do not monitor the patient intraperitoneal pressure during a therapy session. Current systems simply limit the external pressure (or suction) that a pump can apply to the line or lumen that is attached to the patient catheter. If the patient is located below the system, sometimes referred to as a cycler, a gravity head will add to the positive fill pressure that the cycler can apply to the patient catheter. Conversely, if the patient is located above the cycler, the gravity head will decrease from the positive fill pressure that the cycler can apply to the patient catheter.


The monitoring of intraperitoneal pressure would be useful because cyclers will sometimes not fully drain a patient between cycles. Specifically, currently-available cyclers are unable to determine whether a patient absorbed some fluid or whether some fluid is simply not able to be drained out because of the position of the patient or the catheter.


As a result, some currently-available systems utilize a minimum drain threshold to determine the amount of fluid that should be delivered to the patient during the next fill. For example, if 85% of the fill volume has been drained when the cycler determines that the patient is “empty”, the next fill volume will be 100%. If only 80% were drained, the next fill volume would be limited to 95%.


A negative ultrafiltrate (uF) alarm will sound when the patient has retained more than a predetermined percentage of the fill volume. The predetermined percentage can typically be either 50% or 100% of the fill volume. However, the patient can override this alarm if he/she does not feel overfull. The number of times the patients can override the uF alarm during a single therapy may be limited by the software of the cycler. However, the uF alarm typically does not consider the actual ultrafiltrate that may also accumulate in the peritoneal cavity along with the dialysate.


Currently-available cyclers fill the patient to a specific, preprogrammed volume during each cycle. The doctor prescribes this fill volume based upon the patient's size, weight and other factors. However, because currently-available cyclers cannot monitor intraperitoneal pressure, the doctor cannot take this factor into account when formulating the prescription. It is also known that intraperitoneal pressure (IPP) has an effect on ultrafiltration (UF).



FIGS. 1-3 provide schematic illustrations of current APD cyclers. None of them attempt to monitor intraperitoneal pressure.


Referring to FIG. 1, a cycler 10a is illustrated which includes a dialysate container 11, a patient 12 and a drain container 13. The infusion of dialysate from the container 11 into the patient 12 is caused by the gravitational head indicated at 14 while the draining of used dialysate from the patient 12 to the drain container 13 is caused by the drain head indicated at 15. The cycler 10a includes no sensors for monitoring the pressure inside the peritoneum of the patient 12. A single lumen 16 connects both the dialysate container 11 and drain container 13 to the patient 12. Valves 17, 18 operated by the cycler 10a control the flow of either dialysate from the container 11 to the patient 12 or waste material from the patient 12 to the drain container 13.


Turning to FIG. 2, in the cycler 10b, the drain container 13 and dialysate container 11 are contained within a pressurized chamber 19. The chamber 19 can be pressurized or evacuated to either fill or drain the patient. Again, the selective operation of valves 17, 18 control whether dialysate is being transferred to or from the patient 12. Again, no sensors are provided for detecting or monitoring intraperitoneal pressure of the patient 12.


Turning to FIG. 3, in the system 10c, a dialysate container 11 is connected to a pump 21 which, in turn, connects the dialysate container 11 to a common lumen or catheter 16 which is connected to the patient. A fluid flow control valve is provided at 23 and is controlled by the cycler 10c. The drain container 13 is also connected to a pump 24 which, in turn, connects the drain container 13 to the lumen 16. A control valve is again provided at 25.


The drain and fill rates of the cyclers 10a-10c illustrated in FIGS. 1-3 are determined by the gravitational head (see FIG. 1) or the suction or pressure (see FIGS. 2 and 3) applied to the patient line 16. Typically, the cyclers 10a-10c fail to optimize either the fill rate or the drain rate because the pressure is either fixed by the gravitational head or the pressure or suction applied by the chamber 10b of FIG. 2 which occurs at the opposing end of the patient line 16. Thus, without measuring the intraperitoneal pressure or having a way to estimate the same, it is difficult to optimize either the drain or fill rate. In the case of the cycler 10c in FIG. 3, optimizing the drain or fill rate is guesswork due to the lack of any pressure reading at all.


Accordingly, there is a need for an improved cycler that measures patient intraperitoneal pressure during a therapy session, including both during the drain and the fill as well as the dwell. Further, there is a need for an improved cycler that measures intraperitoneal pressure and which would use that data to more completely drain a patient between cycles. Further, there is a need for an improved cycler which would accurately measure intraperitoneal pressure to avoid overfilling a patient. Finally, there is a need for an improved cycler which would monitor intraperitoneal pressure during both the fill and drain cycles to optimize the speed at which the patient is filled and drained and to therefore increase the dwell portion of a therapy session.


SUMMARY

The present invention satisfies the aforenoted needs by providing a system for providing peritoneal dialysis to a patient which comprises a dialysate container connected to the patient with a first pressure sensor connected in-line herebetween, and a drain container connected to the patient with a second pressure sensor connected in-line therebetween.


In an embodiment, the system further comprises a first pump disposed in-line between the dialysate container and the first pressure sensor.


In an embodiment, the dialysate flows from the dialysate container into the patient under a hydrostatic head.


In an embodiment, a second pump is disposed in-line between the drain container and the second pressure sensor.


In an embodiment, the dialysate flows from the patient to the drain container under a hydrostatic head.


In an embodiment, the second pressure sensor measures an intraperitoneal pressure of the patient while dialysate flows from the dialysate container to the patient.


In an embodiment, the first pressure sensor measures an intraperitoneal pressure of the patient while dialysate flows from the patient to the drain container.


In an embodiment, the system further comprises a first lumen connecting the dialysate container to the first sensor and the first sensor to a catheter, and a second lumen connecting the drain container to the second sensor and the second sensor to the catheter, the catheter being connected to the patient, a flow of dialysate from the patient to the drain container evacuating dialysate from the first lumen and causing said dialysate from the first lumen to flow through the second lumen and to the drain container.


In an embodiment, the catheter is a dual lumen catheter.


In an embodiment, the first and second sensors are redundant in-line pressure/vacuum sensors.


In an embodiment, the present invention provides a method for dialyzing a patient comprising the steps of: placing a catheter in a peritoneum of the patient; providing at least one dialysate container; connecting the dialysate container to the catheter with a first lumen that includes a first pressure sensor disposed in-line and between the catheter and the dialysate container; providing at least one drain container; connecting the drain container to the catheter with a second lumen that includes a second pressure sensor disposed in-line and between the catheter and the drain container; transferring dialysate from the dialysate container to the peritoneum of the patient and monitoring an intraperitoneal pressure of the patient with the second pressure sensor; and transferring dialysate from the peritoneum of the patient to the drain container and monitoring the intraperitoneal pressure of the patient with the first pressure sensor.


In an embodiment, the step of transferring dialysate from the dialysate container to the peritoneum of the patient further comprises pumping dialysate from the dialysate container to the patient with a first pump disposed in-line between the dialysate container and the first pressure sensor.


In an embodiment, the step of transferring dialysate from the peritoneum of the patient to the drain container further comprises pumping dialysate from the peritoneum of the patient to the drain container with a second pump disposed in-line between the drain container and the second pressure sensor.


In an embodiment, the dialysate container is disposed vertically above the peritoneum of the patient and the step of transferring dialysate from the dialysate container to the peritoneum of the patient further comprises flowing dialysate from the dialysate container to the patient under a hydrostatic head.


In an embodiment, the drain container is disposed vertically below the peritoneum of the patient and the step of transferring dialysate from the peritoneum of the patient to the drain container further comprises flowing dialysate from the peritoneum of the patient to the drain container under a hydrostatic head.


Other objects and advantages of the invention will become apparent upon reading the following detailed description and appended claims, and upon reference to the accompanying drawings.





BRIEF DESCRIPTION OF THE FIGURES


FIG. 1 illustrates, schematically, a prior art automated peritoneal dialysis system;



FIG. 2 illustrates, schematically, a prior art automated peritoneal dialysis system;



FIG. 3 illustrates, schematically, a prior art automated peritoneal dialysis system;



FIG. 4 illustrates, schematically, an automated peritoneal dialysis system made in accordance with the present invention;



FIG. 5 illustrates, schematically, a second embodiment of an automated peritoneal dialysis system made in accordance with the present invention;



FIG. 6 illustrates, schematically, a third embodiment of an automated peritoneal dialysis system made in accordance with the present invention;



FIG. 7 illustrates, schematically, a fourth embodiment of an automated peritoneal dialysis system made in accordance with the present invention;



FIG. 8 illustrates a pressure sensor made in accordance with the present invention;



FIG. 9 illustrates a fifth embodiment incorporating dual pumping chambers and pressure sensors made in accordance with the present invention;



FIG. 10 illustrates, schematically, a dual lumen catheter that can be utilized with the present invention;



FIG. 11 is a sectional view taken substantially along line 11-11 of FIG. 10;



FIG. 12 illustrates, graphically, the urea concentration in blood and the urea concentration in a dialysate during a multiple dwell dialysis session;



FIG. 13 illustrates, graphically, the concentration of urea in a patient's bloodstream versus the concentration of urea in a dialysate solution for an automated peritoneal dialysis solution practiced in accordance with the prior art; and



FIG. 14 illustrates, graphically, the concentration of urea in a patient's bloodstream versus the concentration of urea in a dialysate for an automated peritoneal dialysis therapy session carried out in accordance with the present invention.





It should be understood that the drawings are not necessarily to scale and that the embodiments are sometimes illustrated by graphic symbols, phantom lines, diagrammatic representations and fragmentary views. In certain instances, details which are not necessary for an understanding of the present invention or which render other details difficult to perceive may have been omitted. It should be understood, of course, that the invention is not necessarily limited to the particular embodiments illustrated herein.


DETAILED DESCRIPTION

Turning to FIG. 4, a cycler 30 includes a dialysate container 11 connected to a pump 31. The pump 31 is connected to a pressure sensor 32. The pump 31 and pressure sensor 32 are disposed in-line in a lumen 33 that connects the dialysate container 11 to a catheter 34. Control valves are provided at 35, 36. A drain container 13 is also connected to a pump 36 which is connected to a sensor 37. The pump 36 and sensor 37 are also connected in-line to a lumen 38 which connects the drain container 13 to the catheter 34. Control valves are again provided at 41, 42. During the fill, the pump 31 pumps dialysate from the container 11 through the lumen 33 and catheter 34 into the peritoneum (not shown) of the patient 12. During this time, the sensor 37 monitors and measures the intraperitoneal pressure. A signal is sent to the controller of the cycler 30 shown schematically at 43. A control panel is indicated generally at 44.


During the drain, the sensor 31 can accurately monitor and measure the intraperitoneal pressure of the patient 12. In the embodiment illustrated in FIG. 4, no pumps or control valves are disposed between the sensor 32 and the patient 12.


Turning to FIG. 5, a cycler 50 is illustrated which includes reversible pumping chambers 51, 52 with sensors 53, 54 disposed between the reversible pumping chambers 51, 52 and the patient 12 respectively. Control valves 55 and 56 are disposed on another side of the reversible pumping chamber 51 and the sensor 53 and control valves 57, 58 are provided on either side of the reversible pumping chamber 52 and sensor 54. The sensors 53, 54 actually measure the pressure on the diaphragms of the reversible pumping chambers 51, 52.


Turning to FIG. 6, a cycler 60 is illustrated with a chamber 61 for accommodating the drain container 13 and a chamber 62 for accommodating the dialysate container 11. Each chamber 61, 62 is equipped with an integrated valve assembly and pressure sensor shown at 63, 64. In the embodiment 60 shown in FIG. 6, the chamber 61 must be capable of being evacuated. Dialysate may flow from the dialysate container 11 by way of gravity or pressure fill. Again, the sensors of the valve assembly/sensor combinations 63, 64 monitor the intraperitoneal pressure of the patient 12 as discussed above.


In the embodiment 70 illustrated in FIG. 7, the dialysate container 11 and drain container 13 are both connected to integrated control valves and pressure sensors 71, 72. Each of the integrated control valves and pressure sensors 71, 72 are connected to lumens 73, 74 respectively which are connected to the catheter 75a by way of a Y-connection. The details of all the Y-connections and clamps are not shown but are known to those skilled in the art. Flow from the dialysate container 11 to the patient is carried out under the gravitational head shown at 75 while flow from the patient to the drain container 13 is carried out under the gravitational head shown at 76.



FIG. 8 illustrates one in-line pressure sensor 80 that is suitable for use with the present invention. Redundant load cells 81, 82 are connected to the flexible pressure sensing membrane 83 by a vacuum connected by the line 84, 85. A lumen connecting the cycler to the patient is shown at 86.



FIG. 9 illustrates a dual-pumping chamber cassette 87 which includes an output line 88 which connects the cassette 87 to the patient and an input line 89 connecting the patient to the cassette 87. The line 90 connects the cassette 87 to the dialysate container (not shown). Each pumping chamber 91, 92 is in communication with all three lines 88, 89 and 90. Thus, every line can be connected to either pumping chamber 91, 92. The pumping chambers 91, 92 are bound on one side by a common diaphragm shown at 93. Flow is controlled by the use of diaphragm valves shown at 94, 95, 96 and 97. Pressure sensors are shown at 120, 121, 122, 123, 124 and 125. However, pressure sensors 123 and 120 are the sensors used to measure intraperitoneal pressure in accordance with the present invention. The remaining sensors 121, 122, 124, 125 are used to monitor the operation of the pumps 126, 127.


When the left diaphragm pump 126 is pushing dialysate to the patient, the sensor 123 can measure the intraperitoneal pressure through the line 89. When the left diaphragm pump 126 is draining fluid from the patient through the line 89, the sensor 120 can measure intraperitoneal pressure through the line 88 and while the right pump 127 is pumping fluid to the drain container (not shown) through the drain line shown schematically at 128. When the right diaphragm pump 127 is being used to drain fluid from the patient, the sensor 120 can measure intraperitoneal pressure while the left diaphragm pump 126 is pumping fluid to the drain container (not shown) through the drain line shown schematically at 129.



FIGS. 10 and 11 illustrate a dual-lumen catheter 100 which includes separate passageways 101, 102. The employment of a dual lumen catheter 100 as compared to a dual lumen patient line can move the point at which the pressure is measured to within the peritoneum itself by way of communication through the separate flowpaths 101, 102. The dual lumen catheter 100 installs like a single lumen catheter, yet will function either as a flow through or a standard catheter. Both fluid pathways 101, 102 are used to withdraw and deliver fluid during the drain and fill. While one pathway delivers fluid, the other pathway drains. The end section, shown generally at 103, is perforated.


A comparison of an APD therapy for a prior art APD cyclers and one manufactured in accordance with the present invention are summarized as follows:















Current APD
Cycler Using


Therapy Parameter
Cycler
Invention



















Total Therapy Volume
15
liters
15
liters


Fill Volume
2.2
liters
2.5
liters max










Fill Pressure Limit
not applicable
14
mm Hg max











Total Therapy Time
8
hours
8
hours


Last (Day) Fill Volume
1,500
ml
1,500
ml









Last Fill Dextrose
Same
Same











Initial Drain Alarm
1,200
ml
1,200
ml









Drain X of N Alarm
80%
80%
















TABLE 1







Comparison of Therapies for Current Cyclers versus Cycler using Invention Method











Therapy Phase
Therapy Parameter
Prior Art Cycler I
Prior Art Cycler 2
Invention Cycler 3

















Initial Drain
Drain Volume
1,200
ml
1,200
ml
1,200
ml



Patient Volume
300
ml
300
ml
300
ml


Fill I of 5
Fill Volume
2,200
ml
2,200
ml
2,500
ml












Patient Volume
2,500
2,500
2,800













Fill Pressure
not applicable
not applicable
12
mm Hg














Drain 1 of 5
Drain Volume
1,800
ml
2,200
ml
2,200
ml



Patient Volume
700
ml
300
ml
600
ml


Fill 2 of 5
Fill Volume
2,200
ml
2,200
ml
2,400
ml



Patient Volume
2,900
ml
2,500
ml
3,000
ml













Patient Pressure
not applicable
not applicable
14
mm Hg














Drain 2 of 5
Drain Volume
1,800
ml
2,200
ml
2,200
ml



Patient Volume
1,100
ml
300
ml
800
ml


Fill 3 of 5
Fill Volume
2,200
ml
2,200
ml
2,200
ml



Patient Volume
3,300
ml
2,500
ml
3,000
ml













Patient Pressure
not applicable
not applicable
14
mm Hg














Drain 3 of 5
Drain Volume
1,801
ml
2,200
ml
2,200
ml



Patient Volume
1,499
ml
300
ml
800
ml


Fill 4 of 5
Fill Volume
2,200
ml
2,200
ml
2,200
ml














Patient Volume
3,699
ml
2,500
3.000
ml













Patient Pressure
not applicable
not applicable
3,000
ml














Drain 4 of 5
I Drain Volume
1,800
ml
2,200
ml.
2,200
ml



Patient Volume
1,899
ml
300
ml
800
ml













Fill 5 of 5
Fill Volume
uF Alarm Bypass




















2,200
ml
2,200
ml
2,200
ml


Patient Volume
4,099 ml
2,500
ml
3,00
ml















Patient Pressure
Patient Wakes Overfull,
not applicable
14
mm Hg




Manually Drains



















1,500
ml






Drain 5 of 5
Drain Volume
1,800
ml
2,200
ml
2,200
ml



Patient Volume
799
ml
300
ml
800
ml


Final Fill
Fill Volume
1,500
ml
1,500
ml
1,500
ml









Inspection of Table 1 shows that cycler 1 woke the patient at around 4:30 in the morning with a negative uF alarm at the beginning of Fill 5. The patient bypassed the alarm because he did not feel overfull and immediately fell back asleep. He woke up about minutes later when he had difficulty breathing and felt extremely overfull. He manually drained about 1500 ml but was unable to go back to sleep. He filed a formal product complaint with the manufacturer.


The data of Table 1 shows that cycler 2 ran a completely normal therapy but the total therapy clearance (calculated based upon the sum of the night patient volumes) was only 84.5% of that obtained by cycler 3, which was using the cycler that used the method of the current invention.


The data of Table 1 shows that cycler 3 ran a completely normal therapy and that the fill volume was limited on one occasion by the maximum fill volume but on four occasions by the patient's intraperitoneal pressure. This patient never felt any discomfort and had no alarms during the night. The limit on the IPP prevented him from being overfilled even though he had successive drains that were not complete. The volume of fluid in his peritoneum never exceeded 3 liters.


The patient on cycler 1 had an intraperitoneal pressure in excess of 14 mm Hg during dwells 3 and 4. His breathing may have been impaired and his heart may have had to work harder but the discomfort was not enough to wake him up from a sound sleep until it peaked at 4,099 ml during dwell 5.


In conclusion, the method of the present invention provides for optimum fills and therefore more clearance while preventing overfills that bring discomfort and inhibit the function of vital body organs. A negative uF alarm would seldom occur because overfills of the required magnitude would be prevented by the IPP sensors.


Calculation of Intraperitoneal Pressure (IPP)


In order to calculate the IPP, one may first calculate the patient head height correction using conservation of energy:

Δ(½ρV2+P−pagh)+Frictional Losses=0


The velocity V of fluid through the patient line is the same at both ends of the line as is the fluid density, so this equation can be written as

(P2−P1)−pag(h2h,)+Frictional Losses=0


which can be rearranged as







Δ





h

=



(


P
1

-

P
2


)

-

Frictional





Losses



ρ






a
g







Example 1





P1=L25 psig=85060 (gram/cm)/(cm2-sec2)
P2=0.9 psig=61240 (gram/cm)/(cm2-sec2)
Frictional Losses=39130(gram/cm)/(cm2-sec2) with flow of 197 cm/min in a 4 mm ID line at a velocity of approximately 172 cm/sec, wherein
ag=981 cm/sec2
ρ=1 gram/cm3







Δ





h

=



(


(

85060
-
30620

)

-
39130

)




(

gram


/


cm

)

/

(


cm
2

-

sec
2


)




1





gram


/



cm
3

*
981





cm


/



sec
2








Δh=−15.6 cm (The patient is 15.6 cm below the membrane)


Example 2





P1=1.25 psig=85060 (gram/cm)/(cm2-sec2)P2=0.45 psig=30620 (gram/cm)/(cm2-sec2)
Frictional Losses=39130 (gram/cm)/(cm2-sec2) with flow of 197 cmn/min in a 4 mm ID line at a velocity of approximately 172 cm/sec, wherein
ag=981 cm/sec2
ρ=1 gram/cm3







Δ





h

=



(


(

85060
-
30620

)

-
39130

)




(

gram


/


cm

)

/

(


cm
2

-

sec
2


)




1





gram


/



cm
3

*
981





cm


/



sec
2








Δh=+15.6 cm (The patient is 15.6 cm above the membrane)


The patient head height can be established at the beginning of each fill. Any changes in the head height that occur during the fill can be attributed to an increase in intraperitoneal pressure (IPP) since the patient is asleep.


Turning to FIG. 12, the concentration gradient between the urea concentration 110 in the patient's blood and the urea concentration 111 in the dialysate for typical APD cyclers is illustrated graphically. Comparing the results illustrated in FIGS. 13 and 14, it is evident that APD cyclers equipped with the sensors of the present invention provide superior results. Specifically, the data illustrated graphically in FIG. 13 was obtained using a prior art APD cycler. The data obtained in FIG. 14 was obtained using an APD cycler utilizing two sensors for monitoring intraperitoneal pressure. Note that the urea concentration 110 in the bloodstream is lower in FIG. 14 than in FIG. 13. Further note, the dialysate volume or fill volume is lower for the therapy illustrated in FIG. 14 than the therapy illustrated in FIG. 13. Thus, the present invention provides improved urea clearance with lower fill volumes.


It should be understood that various changes and modifications to the presently preferred embodiments described herein will be apparent to those skilled in the art. Such changes and modifications may be made without departing from the spirit and scope of the present invention and without diminishing its attendant advantages. It is, therefore, intended that such changes and modifications be covered by the appended claims.

Claims
  • 1. An apparatus for performing peritoneal dialysis comprising: a housing;a peritoneal dialysis supply bag supported by the housing, such that in use the peritoneal dialysis supply bag is located elevationally above a patient;a first valve for controlling gravity flow of fresh peritoneal dialysis fluid from the peritoneal dialysis supply bag to the patient;a second valve for controlling gravity flow of used peritoneal dialysis fluid from the patient to a drain, wherein the drain in use is located elevationally below the patient;a first pressure sensor positioned and arranged with respect to the gravity flow of fresh peritoneal dialysis fluid to provide a first reading used to evaluate a first gravity head pressure;a second pressure sensor positioned and arranged with respect to the gravity flow of used peritoneal dialysis fluid to provide a second reading used to evaluate a second gravity head pressure; anda controller configured to establish the first and second gravity head pressures due to a location of the peritoneal dialysis supply bag and a location of the drain using the first and second readings.
  • 2. The apparatus of claim 1, wherein the drain includes a drain container located below the housing for collecting the used peritoneal dialysis fluid.
  • 3. The apparatus of claim 1, wherein the peritoneal dialysis supply bag is placed on the housing.
  • 4. The apparatus of claim 1, wherein the drain is elevationally disposed below a peritoneal cavity of the patient.
  • 5. The apparatus of claim 1, wherein at least one of (i) the first pressure sensor is integrated with the first valve, or (ii) the second pressure sensor is integrated with the second valve.
  • 6. The apparatus of claim 1, wherein the first and second valves are operable respectively with a fill line and a drain line.
  • 7. The apparatus of claim 1, wherein the first pressure sensor is placed in mechanical communication with a line carrying the gravity flow of fresh peritoneal dialysis fluid.
  • 8. The apparatus of claim 1, wherein the second pressure sensor is placed in mechanical communication with a line carrying the gravity flow of used peritoneal dialysis fluid.
  • 9. An apparatus for performing peritoneal dialysis comprising: a housing;a peritoneal dialysis supply bag located above the housing, such that in use the peritoneal dialysis supply bag is located elevationally above a patient;a first valve for controlling gravity flow of fresh peritoneal dialysis fluid from the peritoneal dialysis supply bag to the patient;a second valve for controlling gravity flow of used peritoneal dialysis fluid from the patient to a drain, wherein the drain in use is located elevationally below the patient;a first pressure sensor positioned and arranged with respect to the gravity flow of fresh peritoneal dialysis fluid to provide a first reading used to evaluate a first gravity head pressure;a second pressure sensor positioned and arranged with respect to the gravity flow of used peritoneal dialysis fluid to provide a second reading used to evaluate a second gravity head pressure; anda controller configured to establish the first and second gravity head pressures due to a location of the peritoneal dialysis supply bag and a location of the drain using the first and second readings, respectively.
  • 10. The apparatus of claim 9, wherein the drain includes a drain container located below the housing for collecting the used peritoneal dialysis fluid.
  • 11. The apparatus of claim 10, wherein the drain container hangs from the housing.
  • 12. The apparatus of claim 9, wherein the peritoneal dialysis supply bag is placed on the housing.
  • 13. The apparatus of claim 9, wherein at least one of (i) the first pressure sensor is integrated with the first valve, or (ii) the second pressure sensor is integrated with the second valve.
  • 14. The apparatus of claim 12, wherein the first pressure sensor is placed in mechanical communication with a line carrying the gravity flow of fresh peritoneal dialysis fluid.
  • 15. The apparatus of claim 9, wherein the second pressure sensor is placed in mechanical communication with a line carrying the gravity flow of used peritoneal dialysis fluid.
  • 16. A method for performing peritoneal dialysis comprising: enabling gravity flow of fresh peritoneal dialysis fluid to a patient;enabling gravity flow of used peritoneal dialysis fluid from the patient;sensing a first pressure of the fresh peritoneal dialysis fluid prior to flowing to the patient and a second pressure of the used peritoneal dialysis fluid prior to flowing from the patient; andprogramming a controller to evaluate (i) a first gravity head pressure from the first sensed pressure prior to a flow of the fresh peritoneal dialysis fluid into a peritoneal cavity of the patient and (ii) a second gravity head pressure from the second sensed pressure prior to a flow of the used peritoneal dialysis fluid from the patient's peritoneal cavity.
  • 17. The method of claim 16, which includes sequencing plural valves to gravity flow the fresh and used peritoneal dialysis fluids to and from the patient.
  • 18. A method for performing peritoneal dialysis comprising: enabling gravity flow of fresh peritoneal dialysis fluid from a source to a patient;enabling gravity flow of used peritoneal dialysis fluid from the patient to a drain;sensing a first pressure of the fresh peritoneal dialysis fluid prior to flowing from the source and a second pressure of the used peritoneal dialysis fluid prior to flowing to the drain; andprogramming a controller to evaluate (i) a first gravity head pressure from the first sensed pressure prior to a flow of fresh peritoneal dialysis fluid into a peritoneal cavity of the patient and (ii) a second gravity head pressure from the second sensed pressure prior to a flow of used peritoneal dialysis fluid to the drain.
  • 19. The method of claim 18, which includes sequencing plural valves to gravity flow the fresh and used peritoneal dialysis fluids from the source and to the drain, respectively.
  • 20. The method of claim 19, which includes integrating at least one of (i) the first pressure sensor with a first valve of the plural valves, or (ii) the second pressure sensor with a second valve of the plural valves.
PRIORITY CLAIM

This application is a continuation of U.S. patent application Ser. No. 13/685,358, filed Nov. 26, 2012, entitled “Method And Apparatus For Monitoring And Controlling Peritoneal Dialysis Therapy,” which is a continuation of U.S. patent application Ser. No. 11/617,543, filed Dec. 28, 2006, having the same title as above, issued as U.S. Pat. No. 8,323,231 on Dec. 4, 2012, which is a continuation of U.S. patent application Ser. No. 10/446,068, filed May 27, 2003, having the same title as above, issued as U.S. Pat. No. 7,507,220 on Mar. 24, 2009, which is a divisional of U.S. patent application Ser. No. 10/078,568, filed Feb. 14, 2002, having the same title as above, issued as U.S. Pat. No. 6,592,542 on Jul. 15, 2003, which is a continuation of U.S. patent application Ser. No. 09/501,778, filed Feb. 10, 2000, having the same title as above, issued as U.S. Pat. No. 6,497,676 on Dec. 24, 2002. Each of the above-referenced disclosures is hereby incorporated by reference and relied upon.

US Referenced Citations (679)
Number Name Date Kind
2286613 Fuller Jan 1942 A
2705223 Renfrew et al. Mar 1955 A
2971876 Phair Feb 1961 A
3255923 Soto Jun 1966 A
3327115 Barlett Jun 1967 A
3375300 Ropp Mar 1968 A
3428828 Korzekwa et al. Feb 1969 A
3485245 Lahr et al. Dec 1969 A
3494897 Reding et al. Feb 1970 A
3507708 Vingnaud Apr 1970 A
3514359 Frese May 1970 A
3561493 Maillard Feb 1971 A
3620215 Tysk et al. Nov 1971 A
3626670 Pecker Dec 1971 A
3645992 Elston Feb 1972 A
3656873 Schiff Apr 1972 A
3689204 Prisk Sep 1972 A
3703959 Raymond Nov 1972 A
3707967 Kitrilakis et al. Jan 1973 A
3709222 Devries Jan 1973 A
3772136 Workman Nov 1973 A
3792643 Scheafer Feb 1974 A
3814799 Wygasch Jun 1974 A
3816033 Fried et al. Jun 1974 A
3858581 Kamen Jan 1975 A
3902490 Jacobsen Sep 1975 A
3912843 Brazier Oct 1975 A
3937758 Castagna Feb 1976 A
3955901 Hamilton May 1976 A
3966358 Heimes et al. Jun 1976 A
3976574 White Aug 1976 A
3979284 Granger Sep 1976 A
3995084 Berger et al. Nov 1976 A
4041103 Davison et al. Aug 1977 A
4058647 Inoue et al. Nov 1977 A
4071040 Moriarty Jan 1978 A
4086653 Gernes Apr 1978 A
4087587 Shida et al. May 1978 A
4087588 Shida et al. May 1978 A
4095012 Schirmer Jun 1978 A
4096859 Agarwal et al. Jun 1978 A
4110303 Gergen et al. Aug 1978 A
4122947 Falla Oct 1978 A
4126132 Portner et al. Nov 1978 A
4137915 Kamen Feb 1979 A
4140118 Jassawalla Feb 1979 A
4142524 Jassawalla et al. Mar 1979 A
4147827 Breidt, Jr. et al. Apr 1979 A
4158530 Bernstein Jun 1979 A
4181245 Garrett et al. Jan 1980 A
4184497 Kolff et al. Jan 1980 A
4187057 Xanthopoulos Feb 1980 A
4199307 Jassawalla Apr 1980 A
4211519 Hogan Jul 1980 A
4233367 Ticknor et al. Nov 1980 A
4235231 Schindler et al. Nov 1980 A
4236880 Archibald Dec 1980 A
4239041 Popovich et al. Dec 1980 A
4240408 Schael Dec 1980 A
4243619 Fraser et al. Jan 1981 A
4252651 Soderstrom Feb 1981 A
4265601 Mandroian May 1981 A
4273121 Jassawalla Jun 1981 A
4277226 Archibald Jul 1981 A
4286597 Gajewski Sep 1981 A
4298714 Levin et al. Nov 1981 A
4303376 Siekmann Dec 1981 A
4306976 Bazzato Dec 1981 A
4310141 Tamura Jan 1982 A
4316466 Babb Feb 1982 A
4322465 Webster Mar 1982 A
4322480 Tuller et al. Mar 1982 A
D264134 Xanthopoulos Apr 1982 S
4327726 Kwong et al. May 1982 A
4332655 Berejka Jun 1982 A
4333088 Diggins Jun 1982 A
4336352 Sakurai et al. Jun 1982 A
4338190 Kraus et al. Jul 1982 A
4351333 Lazarus et al. Sep 1982 A
4368737 Ash Jan 1983 A
4375346 Kraus et al. Mar 1983 A
4381003 Buoncristiani Apr 1983 A
4381005 Bujan Apr 1983 A
4382753 Archibald May 1983 A
4387184 Coquard et al. Jun 1983 A
4391600 Archibald Jul 1983 A
4396382 Goldhaber Aug 1983 A
4398910 Blake et al. Aug 1983 A
4405667 Chirstensen et al. Sep 1983 A
4405774 Miwa et al. Sep 1983 A
4407877 Rasmussen Oct 1983 A
4407888 Crofts Oct 1983 A
4410164 Kamen Oct 1983 A
4410322 Archibald Oct 1983 A
4411649 Kamen Oct 1983 A
4412917 Ahjopalo Nov 1983 A
4417753 Bacehowski Nov 1983 A
4429076 Saito et al. Jan 1984 A
D272651 Mahurkar Feb 1984 S
4430048 Fritsch Feb 1984 A
4438238 Fukushima et al. Mar 1984 A
4449976 Kamen May 1984 A
4456218 Kawabata et al. Jun 1984 A
4464172 Lichtenstein Aug 1984 A
4465481 Blake Aug 1984 A
4468222 Lundquist Aug 1984 A
4472116 Wenstrup Sep 1984 A
4472117 Wenstrup Sep 1984 A
4473342 Iles Sep 1984 A
4479760 Bilstad et al. Oct 1984 A
4479761 Bilstad et al. Oct 1984 A
4479762 Bilstad et al. Oct 1984 A
4479989 Mahal Oct 1984 A
4482584 Hess et al. Nov 1984 A
4490137 Moukheibir Dec 1984 A
4496349 Cosentino Jan 1985 A
4498902 Ash et al. Feb 1985 A
4504038 King Mar 1985 A
4521437 Storms Jun 1985 A
4530759 Schal Jul 1985 A
4537561 Xanthopoulos Aug 1985 A
4543087 Sommercorn et al. Sep 1985 A
4547136 Rothstein Oct 1985 A
4548348 Clements Oct 1985 A
4552552 Polaschegg et al. Nov 1985 A
4559036 Wunsch Dec 1985 A
4559044 Robinson et al. Dec 1985 A
4560472 Granzow et al. Dec 1985 A
4562118 Maruhashi et al. Dec 1985 A
4568723 Lu Feb 1986 A
4573994 Fischell et al. Mar 1986 A
4574173 Bennett Mar 1986 A
4581012 Brown et al. Apr 1986 A
4585436 Davis et al. Apr 1986 A
4586920 Peabody May 1986 A
4588648 Krueger May 1986 A
4599055 Dykstra Jul 1986 A
4599276 Martini Jul 1986 A
4600401 Kamen Jul 1986 A
4613327 Tegrarian et al. Sep 1986 A
4618343 Polaschegg Oct 1986 A
4620690 Kamen Nov 1986 A
RE32303 Lasker et al. Dec 1986 E
4627844 Schmitt Dec 1986 A
4628969 Jurgens, Jr. et al. Dec 1986 A
4634426 Kamen Jan 1987 A
4634430 Polaschegg Jan 1987 A
4636412 Field Jan 1987 A
4639245 Pastrone et al. Jan 1987 A
4640870 Akazawa et al. Feb 1987 A
4642098 Lundquist Feb 1987 A
4643926 Mueller Feb 1987 A
4648810 Schippers et al. Mar 1987 A
4648872 Kamen Mar 1987 A
4657490 Abbott Apr 1987 A
4660568 Cosman Apr 1987 A
4668752 Tominari et al. May 1987 A
4673334 Allington et al. Jun 1987 A
4681564 Landreneau Jul 1987 A
4681797 Van Iseghem Jul 1987 A
4686125 Johnston et al. Aug 1987 A
4687471 Twardowski et al. Aug 1987 A
4692361 Johnston et al. Sep 1987 A
4694848 Jorgensen et al. Sep 1987 A
4696671 Epstein et al. Sep 1987 A
4703773 Hansen et al. Nov 1987 A
4704102 Guthery Nov 1987 A
4707389 Ward Nov 1987 A
4710166 Thompson et al. Dec 1987 A
4717117 Cook Jan 1988 A
4718890 Peabody Jan 1988 A
4724028 Zabielski et al. Feb 1988 A
4726997 Mueller et al. Feb 1988 A
4732795 Ohya et al. Mar 1988 A
4734327 Vicik Mar 1988 A
4735558 Kienholz et al. Apr 1988 A
4735855 Wofford et al. Apr 1988 A
4740582 Coquard et al. Apr 1988 A
4747822 Peabody May 1988 A
4749109 Kamen Jun 1988 A
4753222 Morishita Jun 1988 A
4760114 Haaf et al. Jul 1988 A
4762864 God et al. Aug 1988 A
4764404 Genske et al. Aug 1988 A
4767377 Falla Aug 1988 A
4767651 Starczweski et al. Aug 1988 A
4769134 Allan et al. Sep 1988 A
4772269 Twardowski et al. Sep 1988 A
4772497 Maasola Sep 1988 A
4778356 Hicks Oct 1988 A
4778450 Kamen Oct 1988 A
4778451 Kamen Oct 1988 A
4778697 Genske et al. Oct 1988 A
4784576 Bloom et al. Nov 1988 A
4786697 Cozewith et al. Nov 1988 A
4789714 Cozewith et al. Dec 1988 A
4792488 Schirmer Dec 1988 A
4794942 Yasuda et al. Jan 1989 A
4795782 Lutz et al. Jan 1989 A
4798580 DeMeo et al. Jan 1989 A
4800129 Deak Jan 1989 A
4803102 Raniere et al. Feb 1989 A
4808161 Kamen Feb 1989 A
4816019 Kamen Mar 1989 A
4816343 Mueller Mar 1989 A
4818186 Pastrone et al. Apr 1989 A
4818190 Pelmulder et al. Apr 1989 A
4823552 Ezell et al. Apr 1989 A
4824339 Bainbridge et al. Apr 1989 A
4826482 Kamen May 1989 A
4828545 Epstein et al. May 1989 A
4830586 Herter et al. May 1989 A
4832054 Bark May 1989 A
4834755 Silvestrini et al. May 1989 A
4842582 Mahurkar Jun 1989 A
4842584 Pastrone Jun 1989 A
4842948 Gagliani et al. Jun 1989 A
4848722 Webster Jul 1989 A
4850805 Madsen et al. Jul 1989 A
4852851 Webster Aug 1989 A
4855356 Holub et al. Aug 1989 A
4856259 Woo et al. Aug 1989 A
4856260 Woo et al. Aug 1989 A
4859319 Borsari Aug 1989 A
4861242 Finsterwald Aug 1989 A
4863996 Nakazima et al. Sep 1989 A
4865584 Epstein et al. Sep 1989 A
4871799 Kobayashi et al. Oct 1989 A
4872813 Gorton et al. Oct 1989 A
4873287 Holub et al. Oct 1989 A
4877682 Sauers et al. Oct 1989 A
4885119 Mueller et al. Dec 1989 A
4886431 Soderquist et al. Dec 1989 A
4886432 Kimberlin Dec 1989 A
4895561 Mahurkar Jan 1990 A
4904168 Cavoto et al. Feb 1990 A
4910085 Raniere et al. Mar 1990 A
4923470 Dumican May 1990 A
4927411 Pastrone et al. May 1990 A
4929479 Shishido et al. May 1990 A
4931520 Yamanashi et al. Jun 1990 A
4935004 Cruz Jun 1990 A
4937299 Ewen et al. Jun 1990 A
4941519 Sestak et al. Jul 1990 A
4942735 Mushika et al. Jul 1990 A
4946616 Falla et al. Aug 1990 A
4950720 Randall, Jr. et al. Aug 1990 A
4957966 Nishio et al. Sep 1990 A
4957967 Mizuno et al. Sep 1990 A
4966795 Genske et al. Oct 1990 A
4976162 Kamen Dec 1990 A
4977213 Giroud-Abel et al. Dec 1990 A
4990054 Janocko Feb 1991 A
4992511 Yamamoto et al. Feb 1991 A
4996054 Pietsch et al. Feb 1991 A
4999254 Ofstein Mar 1991 A
5002471 Perlov Mar 1991 A
5003019 Ishimaru et al. Mar 1991 A
5004459 Peabody Apr 1991 A
5006050 Cooke et al. Apr 1991 A
5006601 Lutz et al. Apr 1991 A
5008204 Stehling Apr 1991 A
5008356 Ishimaru et al. Apr 1991 A
5017652 Abe et al. May 1991 A
5019140 Bowser et al. May 1991 A
5034457 Serini et al. Jul 1991 A
5034458 Serini et al. Jul 1991 A
5037385 O'Byrne Aug 1991 A
5043088 Falla Aug 1991 A
5044902 Malbec Sep 1991 A
5053023 Martin Oct 1991 A
5053457 Lee Oct 1991 A
5057073 Martin Oct 1991 A
5057075 Moncrief et al. Oct 1991 A
5062774 Kramer et al. Nov 1991 A
5071686 Genske et al. Dec 1991 A
5071911 Furuta et al. Dec 1991 A
5071912 Furuta et al. Dec 1991 A
5075376 Furuta et al. Dec 1991 A
5079295 Furuta et al. Jan 1992 A
5085649 Flynn Feb 1992 A
5087677 Brekner et al. Feb 1992 A
5088515 Kamen Feb 1992 A
5093164 Bauer et al. Mar 1992 A
5093194 Touhsaent et al. Mar 1992 A
5094820 Maxwell et al. Mar 1992 A
5094921 Itamura et al. Mar 1992 A
5098262 Wecker et al. Mar 1992 A
5098413 Trudell et al. Mar 1992 A
5106366 Steppe Apr 1992 A
5106368 Uldall et al. Apr 1992 A
5108844 Blumberg et al. Apr 1992 A
5110642 Genske et al. May 1992 A
5116906 Mizuno et al. May 1992 A
5120303 Hombrouckx Jun 1992 A
5125891 Hossain et al. Jun 1992 A
5129894 Sommermeyer et al. Jul 1992 A
5132363 Furuta et al. Jul 1992 A
5133650 Sunderland et al. Jul 1992 A
5135485 Cohen et al. Aug 1992 A
5135785 Milton Aug 1992 A
5141493 Jacobsen et al. Aug 1992 A
5145731 Lund et al. Sep 1992 A
5154979 Kerschbaumer et al. Oct 1992 A
5159004 Furuta et al. Oct 1992 A
5163900 Wortrich Nov 1992 A
5164267 D'Heur et al. Nov 1992 A
5176634 Smith et al. Jan 1993 A
5176956 Jevne et al. Jan 1993 A
5178182 Kamen Jan 1993 A
5183706 Bekele Feb 1993 A
5185084 Lapidus et al. Feb 1993 A
5185189 Stenger et al. Feb 1993 A
5188593 Martin Feb 1993 A
5189091 Laughner Feb 1993 A
5193913 Rosenbaum Mar 1993 A
5193990 Kamen et al. Mar 1993 A
5194316 Horner et al. Mar 1993 A
5195960 Hossain et al. Mar 1993 A
5195986 Kamen Mar 1993 A
5196254 Alliyama Mar 1993 A
5197951 Mahurkar Mar 1993 A
5203943 Nornberg et al. Apr 1993 A
5206290 Mizuno et al. Apr 1993 A
5207642 Orkin et al. May 1993 A
5207650 Martin May 1993 A
5207983 Liebert et al. May 1993 A
5209723 Twardowski et al. May 1993 A
5211201 Kamen et al. May 1993 A
5212238 Schelbelhoffer et al. May 1993 A
5213483 Flaherty et al. May 1993 A
5215312 Knappe et al. Jun 1993 A
5215450 Tamari Jun 1993 A
5218048 Abe et al. Jun 1993 A
5218049 Yamamoto et al. Jun 1993 A
5221255 Mahurkar et al. Jun 1993 A
5221256 Mahurkar Jun 1993 A
5222946 Kamen Jun 1993 A
5230614 Zanger et al. Jul 1993 A
5230934 Sakano et al. Jul 1993 A
5230935 Delimoy et al. Jul 1993 A
5238997 Bauer et al. Aug 1993 A
5241985 Faust et al. Sep 1993 A
5244971 Jean-Marc Sep 1993 A
5245151 Chamberlain et al. Sep 1993 A
5245693 Ford et al. Sep 1993 A
5247434 Peterson et al. Sep 1993 A
5250027 Lewis et al. Oct 1993 A
5250041 Folden et al. Oct 1993 A
5252044 Raines et al. Oct 1993 A
5254084 Geary Oct 1993 A
5254824 Chamberlain et al. Oct 1993 A
5257917 Minarik et al. Nov 1993 A
5258230 La Fleur et al. Nov 1993 A
5272235 Wakatsuru et al. Dec 1993 A
5277820 Ash Jan 1994 A
5278231 Chundury Jan 1994 A
5278377 Tsai Jan 1994 A
5288531 Falla et al. Feb 1994 A
5288560 Sudo et al. Feb 1994 A
5288799 Schmidt et al. Feb 1994 A
5290856 Okamoto Mar 1994 A
5292306 Wynkoop et al. Mar 1994 A
5294763 Chamberlain et al. Mar 1994 A
5302093 Owens et al. Apr 1994 A
5306542 Bayer Apr 1994 A
5312867 Mitsuno et al. May 1994 A
5316452 Bogen et al. May 1994 A
5317059 Chundury et al. May 1994 A
5322519 Ash Jun 1994 A
5331057 Brekner et al. Jul 1994 A
5332372 Reynolds Jul 1994 A
5334139 Jeppsson et al. Aug 1994 A
5336173 Folden Aug 1994 A
5336190 Moss et al. Aug 1994 A
5338293 Jeppsson et al. Aug 1994 A
5342886 Glotin et al. Aug 1994 A
5344292 Rabenau et al. Sep 1994 A
5346471 Raulerson Sep 1994 A
5348794 Takahashi Sep 1994 A
5350357 Kamen Sep 1994 A
5350358 Martin Sep 1994 A
5356676 Von Widdern et al. Oct 1994 A
5359001 Epple et al. Oct 1994 A
5360648 Falla et al. Nov 1994 A
5364344 Beattie et al. Nov 1994 A
5364371 Kamen Nov 1994 A
5364486 Falla et al. Nov 1994 A
5371151 Berge et al. Dec 1994 A
5378126 Abrahamson et al. Jan 1995 A
5378230 Mahurkar Jan 1995 A
5378543 Muruta et al. Jan 1995 A
5378800 Mok et al. Jan 1995 A
5380276 Miller et al. Jan 1995 A
5382630 Stehling et al. Jan 1995 A
5382631 Stehling et al. Jan 1995 A
5385540 Abbott et al. Jan 1995 A
5387645 Montag et al. Feb 1995 A
5389243 Kaplan Feb 1995 A
5397222 Moss et al. Mar 1995 A
5401342 Vincent et al. Mar 1995 A
5409355 Brooke Apr 1995 A
5415528 Ogden et al. May 1995 A
5421208 Packard et al. Jun 1995 A
5421814 Geary Jun 1995 A
5421823 Kamen et al. Jun 1995 A
5422409 Brekner et al. Jun 1995 A
5423768 Folden et al. Jun 1995 A
5427509 Chapman et al. Jun 1995 A
5429485 Dodge Jul 1995 A
5431626 Bryant et al. Jul 1995 A
5433588 Monk et al. Jul 1995 A
5438510 Bryant et al. Aug 1995 A
5439587 Stankowski et al. Aug 1995 A
5442919 Wilhelm Aug 1995 A
5445506 Afflerbaugh et al. Aug 1995 A
5445610 Evert Aug 1995 A
5446270 Chamberlain et al. Aug 1995 A
5457249 Sagane et al. Oct 1995 A
5458468 Ye et al. Oct 1995 A
5460490 Carr et al. Oct 1995 A
5460493 Deniega et al. Oct 1995 A
5462416 Dennehy et al. Oct 1995 A
5464388 Merte et al. Nov 1995 A
5464398 Haindl Nov 1995 A
5474683 Bryant et al. Dec 1995 A
5475060 Brekner et al. Dec 1995 A
5476368 Rabenau et al. Dec 1995 A
5480294 Di Perna et al. Jan 1996 A
5482438 Anderson et al. Jan 1996 A
5482440 Dennehey et al. Jan 1996 A
5482770 Bekele Jan 1996 A
5487649 Dorsey, III et al. Jan 1996 A
5498338 Kruger et al. Mar 1996 A
5498677 Weller Mar 1996 A
5508051 Falla et al. Apr 1996 A
5514102 Winterer et al. May 1996 A
5518378 Neftel et al. May 1996 A
5522769 DeGuiseppi Jun 1996 A
5525659 Falla et al. Jun 1996 A
5526844 Kamen Jun 1996 A
5527274 Zakko Jun 1996 A
5529708 Palmgren et al. Jun 1996 A
5530065 Farley et al. Jun 1996 A
5533389 Kamen et al. Jul 1996 A
5534606 Bennett et al. Jul 1996 A
5536412 Ash Jul 1996 A
5540568 Rosen et al. Jul 1996 A
5540808 Vincent et al. Jul 1996 A
5542919 Simon et al. Aug 1996 A
5552504 Bennett et al. Sep 1996 A
5554013 Owens et al. Sep 1996 A
5556263 Jacobsen et al. Sep 1996 A
5569026 Novak Oct 1996 A
5569182 Twardowski et al. Oct 1996 A
5570716 Kamen et al. Nov 1996 A
5575310 Kamen et al. Nov 1996 A
5575632 Morris et al. Nov 1996 A
5578012 Kamen et al. Nov 1996 A
5580460 Polaschegg Dec 1996 A
5580914 Falla et al. Dec 1996 A
5583192 Bennett et al. Dec 1996 A
5586868 Lawless et al. Dec 1996 A
5588815 Zaleski, II Dec 1996 A
5588816 Abbott et al. Dec 1996 A
5591344 Kenley et al. Jan 1997 A
5601420 Warner et al. Feb 1997 A
5603354 Jacobsen et al. Feb 1997 A
5609572 Lang Mar 1997 A
5610253 Hatke et al. Mar 1997 A
5620312 Hyman et al. Apr 1997 A
5620425 Hefferman et al. Apr 1997 A
5628908 Kamen et al. May 1997 A
5629398 Okamoto et al. May 1997 A
5630935 Treu May 1997 A
5632606 Jacobsen et al. May 1997 A
5634896 Bryant et al. Jun 1997 A
5637100 Sudo Jun 1997 A
5637400 Brekner et al. Jun 1997 A
5641405 Keshaviah et al. Jun 1997 A
5643201 Peabody et al. Jul 1997 A
5645734 Kenley et al. Jul 1997 A
5650471 Abe et al. Jul 1997 A
5655897 Neftel et al. Aug 1997 A
5669764 Behringer et al. Sep 1997 A
5674944 Falla et al. Oct 1997 A
5676530 Nazarifar Oct 1997 A
5685867 Twardowski et al. Nov 1997 A
5686527 Laurin et al. Nov 1997 A
5693728 Okamoto et al. Dec 1997 A
5698645 Weller et al. Dec 1997 A
5698654 Nye et al. Dec 1997 A
5707751 Garza et al. Jan 1998 A
5711654 Afflerbaugh Jan 1998 A
5718569 Holst Feb 1998 A
5718692 Schon et al. Feb 1998 A
5721025 Falla et al. Feb 1998 A
5722947 Jeppsson et al. Mar 1998 A
5723189 Sudo Mar 1998 A
5733991 Rohrman et al. Mar 1998 A
5741125 Neftel et al. Apr 1998 A
5744664 Brekner et al. Apr 1998 A
5752813 Tyner et al. May 1998 A
5756623 Krueder et al. May 1998 A
5758563 Robinson Jun 1998 A
5776111 Tesio Jul 1998 A
5782575 Vincent et al. Jul 1998 A
5783072 Kenley et al. Jul 1998 A
5788670 Reinhard et al. Aug 1998 A
5788671 Johnson Aug 1998 A
5788680 Linder Aug 1998 A
5790752 Anglin et al. Aug 1998 A
5792824 Natori Aug 1998 A
5795326 Simán Aug 1998 A
5795945 Natori Aug 1998 A
5807075 Jacobsen et al. Sep 1998 A
5807311 Palestrant Sep 1998 A
5814004 Tamari Sep 1998 A
5816779 Lawless et al. Oct 1998 A
5836908 Beden et al. Nov 1998 A
5849843 Laurin et al. Dec 1998 A
5854347 Laurin et al. Dec 1998 A
5854349 Abe et al. Dec 1998 A
5863986 Herrmann-Schonherr et al. Jan 1999 A
5871566 Rutz Feb 1999 A
5872201 Cheung et al. Feb 1999 A
5879768 Falla et al. Mar 1999 A
5899674 Jung et al. May 1999 A
5906598 Giesler et al. May 1999 A
5919369 Ash Jul 1999 A
5921951 Morris Jul 1999 A
5924975 Goldowsky Jul 1999 A
5927956 Lim et al. Jul 1999 A
5928196 Johnson et al. Jul 1999 A
5931647 Jacobsen et al. Aug 1999 A
5931808 Pike Aug 1999 A
5931829 Burbank et al. Aug 1999 A
5938634 Packard Aug 1999 A
5942579 Falla et al. Aug 1999 A
5944495 Jacobsen et al. Aug 1999 A
5944684 Roberts et al. Aug 1999 A
5947953 Ash et al. Sep 1999 A
5961486 Twardowski et al. Oct 1999 A
5964796 Imran Oct 1999 A
5965433 Gardetto et al. Oct 1999 A
5968009 Simán Oct 1999 A
5976103 Martin Nov 1999 A
5980481 Gorsuch Nov 1999 A
5980495 Heinz et al. Nov 1999 A
5983136 Kamen Nov 1999 A
5984762 Tedeschi et al. Nov 1999 A
5989206 Prosl et al. Nov 1999 A
5989423 Kamen et al. Nov 1999 A
5990254 Weller et al. Nov 1999 A
5993949 Rosenbaum et al. Nov 1999 A
5998019 Rosenbaum et al. Dec 1999 A
6001078 Reekers Dec 1999 A
6001079 Pourchez Dec 1999 A
6001201 Vincent et al. Dec 1999 A
6007310 Jacobsen et al. Dec 1999 A
6007520 Sudo Dec 1999 A
6017194 North, Jr. Jan 2000 A
6020444 Riedel et al. Feb 2000 A
6030359 Nowosielski Feb 2000 A
6036458 Cole et al. Mar 2000 A
6036668 Mathis Mar 2000 A
6041801 Gray et al. Mar 2000 A
6045648 Palmgren et al. Apr 2000 A
6048329 Thompson et al. Apr 2000 A
6056522 Johnson May 2000 A
6059544 Jung et al. May 2000 A
6060572 Gillis et al. May 2000 A
6065270 Reinhard et al. May 2000 A
6065941 Gray et al. May 2000 A
6068936 Pfeiffer et al. May 2000 A
6070761 Bloom et al. Jun 2000 A
6074183 Allen et al. Jun 2000 A
6074359 Keshaviah et al. Jun 2000 A
6074374 Fulton Jun 2000 A
6077246 Kullas et al. Jun 2000 A
6106948 Wang et al. Aug 2000 A
6109895 Ray et al. Aug 2000 A
6110549 Hamada et al. Aug 2000 A
6110617 Feres Aug 2000 A
6114457 Markel et al. Sep 2000 A
6117106 Wasicek et al. Sep 2000 A
6117465 Falla et al. Sep 2000 A
6121394 Sugimoto et al. Sep 2000 A
6126403 Yamada Oct 2000 A
6126631 Loggie Oct 2000 A
6129699 Haight et al. Oct 2000 A
6132405 Nilsson et al. Oct 2000 A
6136744 Gillis et al. Oct 2000 A
6146354 Beil Nov 2000 A
6147025 Gillis et al. Nov 2000 A
6149621 Makihara Nov 2000 A
6156016 Maginot Dec 2000 A
6159195 Ha et al. Dec 2000 A
6165154 Gray et al. Dec 2000 A
6168862 Rosenbaum et al. Jan 2001 B1
6169052 Brekner et al. Jan 2001 B1
6171670 Sudo et al. Jan 2001 B1
6186752 Deniega et al. Feb 2001 B1
6190349 Ash et al. Feb 2001 B1
6190371 Maginot et al. Feb 2001 B1
6191254 Falla et al. Feb 2001 B1
6193684 Burbank et al. Feb 2001 B1
6203296 Ray et al. Mar 2001 B1
6206849 Martin et al. Mar 2001 B1
6208107 Maske et al. Mar 2001 B1
6210361 Kamen et al. Apr 2001 B1
6221648 La Page et al. Apr 2001 B1
6223130 Gray et al. Apr 2001 B1
6225426 Gillis et al. May 2001 B1
6225427 Burton et al. May 2001 B1
6228047 Dadson May 2001 B1
6231320 Lawless et al. May 2001 B1
6234991 Gorsuch May 2001 B1
6234997 Kamen et al. May 2001 B1
RE37208 Winter et al. Jun 2001 E
6245039 Brugger et al. Jun 2001 B1
6248092 Miraki et al. Jun 2001 B1
6248093 Moberg Jun 2001 B1
6254567 Treu et al. Jul 2001 B1
6255396 Ding et al. Jul 2001 B1
6258079 Burbank et al. Jul 2001 B1
6261655 Rosenbaum et al. Jul 2001 B1
6266664 Russell-Falla et al. Jul 2001 B1
6270673 Belt et al. Aug 2001 B1
6280408 Sipin Aug 2001 B1
6280423 Davey et al. Aug 2001 B1
6290669 Zicherman Sep 2001 B1
6293926 Sorensen et al. Sep 2001 B1
6302653 Bryant et al. Oct 2001 B1
6302875 Makower et al. Oct 2001 B1
6343614 Gray et al. Feb 2002 B1
6364857 Gray et al. Apr 2002 B1
6372848 Yang et al. Apr 2002 B1
6382923 Gray May 2002 B1
6409699 Ash Jun 2002 B1
6416293 Bouchard Jul 2002 B1
6484383 Herklotz Nov 2002 B1
6491656 Morris Dec 2002 B1
6491658 Miura et al. Dec 2002 B1
6497676 Childers et al. Dec 2002 B1
6503062 Gray et al. Jan 2003 B1
6542761 Jahn et al. Apr 2003 B1
6558340 Traeger May 2003 B1
6561996 Gorsuch May 2003 B1
6561997 Weitzel et al. May 2003 B1
6585682 Haraldsson et al. Jul 2003 B1
6592542 Childers et al. Jul 2003 B2
6595948 Suzuki et al. Jul 2003 B2
6666842 Sakai Dec 2003 B1
6672841 Herklotz et al. Jan 2004 B1
6743201 Dönig et al. Jun 2004 B1
6752172 Lauer Jun 2004 B2
6808369 Grey et al. Oct 2004 B2
6814547 Childers et al. Nov 2004 B2
6869538 Yu et al. Mar 2005 B2
6948918 Hansen Sep 2005 B2
6949079 Westberg et al. Sep 2005 B1
7004924 Brugger et al. Feb 2006 B1
7988686 Beden et al. Aug 2011 B2
8323231 Childers et al. Dec 2012 B2
20010014793 Brugger et al. Aug 2001 A1
20010018937 Nemoto Sep 2001 A1
20010034502 Moberg et al. Oct 2001 A1
20020041825 Scheunert et al. Apr 2002 A1
20020045851 Suzuki et al. Apr 2002 A1
20020062109 Lauer May 2002 A1
20020077598 Yap et al. Jun 2002 A1
20030012905 Zumbrum et al. Jan 2003 A1
20030195454 Wariar et al. Oct 2003 A1
20030204162 Childers et al. Oct 2003 A1
20030220600 Gotch et al. Nov 2003 A1
20040254513 Shang et al. Dec 2004 A1
20050118038 Grey et al. Jun 2005 A1
20090216211 Beden et al. Aug 2009 A1
Foreign Referenced Citations (99)
Number Date Country
1226740 Oct 1966 DE
1964735 Jul 1971 DE
133 411 Jan 1979 DE
3522782 Jan 1987 DE
251 904 Dec 1987 DE
3739556 Jun 1989 DE
39 37 865 Jun 1990 DE
19837667 Mar 2000 DE
19919572 Nov 2000 DE
19929572 Nov 2000 DE
10034711 Feb 2002 DE
10039196 Feb 2002 DE
10042324 Feb 2002 DE
10053441 May 2002 DE
10157924 Jun 2003 DE
10224750 Dec 2003 DE
0028371 May 1981 EP
0 033 096 Aug 1981 EP
0 052 004 May 1982 EP
0 097 432 Jan 1984 EP
0 156 464 Oct 1985 EP
0 157 024 Oct 1985 EP
0 206 195 Nov 1986 EP
0204260 Dec 1986 EP
0 306 664 Mar 1989 EP
0319272 Jun 1989 EP
0 333 308 Sep 1989 EP
0 381 042 Aug 1990 EP
0402505 Dec 1990 EP
0011935 May 1991 EP
0 216 509 Sep 1991 EP
0248632 Apr 1992 EP
0 497 567 Aug 1992 EP
0 504 934 Sep 1992 EP
0 524 802 Jan 1993 EP
0 535 874 Apr 1993 EP
0 554 722 Aug 1993 EP
0 283 164 May 1995 EP
0 492 982 Aug 1995 EP
0 684 845 Dec 1995 EP
0 430 585 Jan 1996 EP
0 156 464 May 1996 EP
0 582 355 May 1996 EP
0 709 105 May 1996 EP
0 660 725 Jul 1996 EP
0 203 799 Aug 1996 EP
0 384 694 Sep 1996 EP
0 497 567 Sep 1996 EP
0 291 208 Aug 1997 EP
0 790 063 Aug 1997 EP
0 291 208 Nov 1998 EP
0 680 401 Jan 1999 EP
0947814 Oct 1999 EP
0956876 Nov 1999 EP
1 110 564 Jun 2001 EP
1 110 565 Jun 2001 EP
0 709 105 Dec 2001 EP
0957954 May 2003 EP
1314443 May 2003 EP
1403519 Mar 2004 EP
1546556 Dec 2006 EP
1754890 Feb 2007 EP
2371931 Jun 1978 FR
2440740 Jun 1980 FR
1326236 Aug 1973 GB
2245 496 Jan 1992 GB
03-095286 Apr 1991 JP
H03-96850 Oct 1991 JP
05-277154 Oct 1993 JP
11-071554 Mar 1999 JP
1201264 Oct 2001 PT
331736 Jan 1985 SE
WO 8601115 Feb 1968 WO
WO 8402473 Jul 1984 WO
WO 8504813 Nov 1985 WO
8901795 Mar 1986 WO
8705223 Sep 1986 WO
WO 8803389 May 1988 WO
9013795 Nov 1990 WO
WO 9102484 Mar 1991 WO
WO 0191829 Dec 1991 WO
WO 9215349 Sep 1992 WO
WO 9301845 Feb 1993 WO
9420158 Sep 1994 WO
WO 9535124 Dec 1995 WO
WO 9708054 Mar 1997 WO
WO 9817333 Apr 1998 WO
WO 9822167 May 1998 WO
WO 9827926 Jul 1998 WO
WO 9844043 Oct 1998 WO
WO 9850088 Nov 1998 WO
WO 9906082 Feb 1999 WO
WO 9907301 Feb 1999 WO
WO 9948990 Sep 1999 WO
WO 9906082 Nov 1999 WO
WO 0010385 Mar 2000 WO
WO 0020050 Apr 2000 WO
WO 0158509 Aug 2001 WO
WO 2004029457 Apr 2004 WO
Non-Patent Literature Citations (118)
Entry
Durand, P. et al., APD: Clinical Measurement of the Maximal Acceptable Intraperitoneal Volume, Advances in Peritoneal Dialysis, vol. 10, 1994, pp. 63-67.
Durand, P. et al., Measurement of Hydrostatic Intraperitoneal Pressure: A Necessary Routine Test in Peritoneal Dialysis: Peritonial Dialysis International, vol. 16, 1996, pp. S84-S87.
Durand, P. et al., Routine Measurement of Hydrostatic Intraperitoneal Pressure, Advances in Peritoneal Dialysis, pp. 108-112.
Gotloib, L. et al., Hemodynamic Effects of Increasing Intra-Abdominal Pressure in Peritoneal Dialysis, pp. 41-43.
Mathieu et al., Measurement of Hydrostatic Intraperitoneal Pressure, Advances in Peritoneal Dialysis, vol. 10, 1994, pp. 59-62.
Twardowski, Z. et al., High Volume, Low Frequency Continuous Ambulatory Peritoneal Dialysis, Kidney International, Vo. 23, 1983, pp. 64-70.
Fresenius Medical Care, The Sign for Safe and Bicompatible CAPD, Stay Safe® Balance, 8 pages.
Help Cards entitled “HomeChoice, Augomated PD System”, from Baxter Healthcare Corporation, 1994.
Help Cards entitled “PAC-Xtra Help Cards”, from Baxter Healthcare Corporation, 1991.
Booklet entitled “HomeChoice, Patient At-Home Guide, HomeChoice Automated PD System”, from Baxter Healthcare Corporation, 1994.
Brochure entitled “Pac-Xtra, Peritoneal Automated Cycler with X-Connector Set”, from Baxter Healthcare Corporation, 1990.
Brochure entitled “PD Today, Understanding Home Training Fees: A Physician Perspective”, from Baxter Healthcare Corporation, 1999.
Booklet entitled “HomeChoice Automated PD System, Advanced Technology Creates a New Way to Go Home”, from Baxter Healthcare Corporation, 1994.
Intraperitoneal Pressure, Presentation by Jane Hollis, et al., Addenbrooke's Dialysis Center, UK, 1998.
“We Have a Gripe With Equal Treatment,” Brochure published by Baxter Healthcare Corporation (1988).
Defendants' Preliminary Invalidity Contentions for U.S. Pat. No. 5,421,823 Aug. 24, 2007.
Appendix A: U.S. Pat. No. 3,620,215 Alone and in Combination with Other Prior Art References.
Appendix C: U.S. Pat. No. 4,412,917 in Combination with Other Prior Art References.
Appendix D: U.S. Pat. No. 4,498,900 in Combination with Other Prior Art References.
Appendix E: U.S. Pat. No. 3,545,438 in Combination with Other Prior Art References.
Appendix F: U.S. Pat. No. 5,004,459 in Combination with Other Prior Art References.
Defendants' Preliminary Invalidity Contentions for U.S. Pat. No. 5,421,823, Baxter Healthcare Corporation v. Fresenius Medical Care Holdings, Case No. C 07-01359 PJH (JL), filed Aug. 24, 2007.
Defendants' Supplemental Invalidity Contentions for U.S. Pat. No. 5,421,823, Baxter Healthcare Corporation v. Fresenius Medical Care Holdings, Case No. C 07-01359 PJH (JL), filed Jan. 31, 2008.
Defendants' Preliminary Invalidity Contentions for U.S. Pat. No. 6,503,062, Baxter Healthcare Corporation v. Fresenius Medical Care Holdings, Case No. C 07-01359 PJH (JL), filed Jan. 31, 2008.
Defendants' Preliminary Invalidity Contentions for U.S. Pat. No. 6,808,369, Baxter Healthcare Corporation v. Fresenius Medical Care Holdings, Case No. C 07-01359 PJH (JL), filed Jan. 31, 2008.
Defendants' Preliminary Invalidity Contentions for U.S. Pat. No. 5,324,422, Baxter Healthcare Corporation v. Fresenius Medical Care Holdings, Case No. C 07-01359 PJH (JL), filed Jan. 31, 2008.
Defendants' Preliminary Invalidity Contentions for U.S. Pat. No. 5,438,510, Baxter Healthcare Corporation v. Fresenius Medical Care Holdings, Case No. C 07-01359 PJH (JL), filed Jan. 31, 2008.
Defendants' Preliminary Invalidity Contentions for U.S. Pat. No. 6,814,547, Baxter Healthcare Corporation v. Fresenius Medical Care Holdings, Case No. C 07-01359 PJH (JL), filed Jan. 31, 2008.
Defendants' Preliminary Invalidity Contentions for U.S. Pat. No. 5,431,626, Baxter Healthcare Corporation v. Fresenius Medical Care Holdings, Case No. C 07-01359 PJH (JL), filed Jan. 31, 2008.
Defendants' Preliminary Invalidity Contentions for U.S. Pat. No. 6,929,751, Baxter Healthcare Corporation v. Fresenius Medical Care Holdings, Case No. C 07-01359 PJH (JL), filed Jan. 31, 2008.
Defendants' Preliminary Invalidity Contentions for U.S. Pat. No. 7,083,719, Baxter Healthcare Corporation v. Fresenius Medical Care Holdings, Case No. C 07-01359 PJH (JL), filed Jan. 31, 2008.
Defendants' Final Invalidity Contentions for U.S. Pat. No. 6,814,547, Baxter Healthcare Corporation v. Fresenius Medical Care Holdings, Case No. C 07-01359 PJH (JL), filed Apr. 1, 2009.
Fresenius 90/2 Peritoneal Therapy Cycler (on information and belief, on sale in United States by 1991).
Blumenkrantz et al., Applications of the Redy Sorbent System to Hemodialysis and Peritoneal Dialysis, Artificial Organs, vol. 3, No. 3 (Aug. 1979).
Blumenkrantz et al., Development of a Sorbent Peritoneal Dialysate Regeneration System—A Progress Report, European Dialysis and Transplant Association 1978.
Blumenkrantz and Roberts, Progress in Peritoneal Dialysis: a Historical Prospective, Contributions to Nephrology, vol. 17, pp. 101-110 (1979).
Diaz-Buxo, CCPD is even better than CAPD, Kidney International, vol. 28, Suppl. 17, pp. S-26-S-28 (1985).
Diaz-Buxo, CCPD Technique and Current Clinical Experience (1982).
Diaz-Buxo, et al., Continuous Cyclic Peritoneal Dialysis: A Preliminary Report, Artificial Organs, vol. 5, No. 2, pp. 157-161 (May 1981).
Diaz-Buxo, Current Status of Continuous Cyclic Peritoneal Dialysis (CCPD), Peritoneal Dialysis International, vol. 9, pp. 9-14 (1989).
Diaz-Buxo, Issues in Nephrology: Continuous Cyclic Peritoneal Dialysis, NAPHT News, Feb. 1983, pp. 12-14.
Diaz-Buxo, Peritoneal Dialysis Reverse Osmosis Machines and Cyclers, Dialysis Therapy, pp. 41-48 (1986).
Drukker et al., Replacement of Renal Function by Dialysis, 2nd Ed., Ch. 21, 1983.
Lewin and Maxwell, Sorbent-Based Regenerating Peritoneal Dialysis, Sorbents and Their Clinical Applications, pp. 353-374 (1980).
Lewin et al., Sorbent for Application in the Treatment of ESRD Patients, Annual Progress Report re Contract #N01-AM-9-2215, submitted Jun. 22, 1982.
Ratnu, et al., A New Technique—Semicontinuous Rapid Flow, High Volume Exchange—For Effective Peritoneal Dialysis in Shorter Periods, Nephron, vol. 31, pp. 159-163 (1982).
Twardowski, Peritoneal Dialysis: Current Technology and techniques, Postgraduate Medicine, vol. 85, No. 5 (Apr. 1989).
Product Evaluation Reports: Peritoneal Dialysis Machine “Pac-X,” Hospital Materials Management, vol. 12, No. 11, p. 16 (Nov. 1987).
PD700 Peritoneal Dialyser Users Hand-book, Dec. 1977.
Brochure entitled, Peritoneal Dialyser PD700, May 1979.
Bergstrom et al., An Automated Apparatus for Peritoneal Dialysis with Volumetric Fluid Balance Measurement, reprinted from Dialysis & Transplantation, Jun./Jul. 1976.
U. Callsen, Peritoneal-Dialysator PD700, Prakt. Anasth. 9 (1974).
Piazolo et al., Erfahrungen mit einem neuen vollautomatsischen Paritoneal-dialysegerat, Munchener Medizinische Wochenschrift, 1972.
Technical Note, PD700 Peritoneal Dialyser, Jan. 29, 1979.
Elsevier Science Ltd., Air-Operated Diaphragm Pumps, World Pumps, Jan. 1996, at 38.
Bran & Luebbe GmbH, Diaphragm Metering Pumps, Chem. Eng'g Progress, Apr. 1987, at 18-24.
W.M. Phillips, J.A. Brighton & W.S. Pierce, Artificial Heart Evaluation Using Flow Visualization Techniques, published in Transactions: American Society for Artificial Internal Organs, vol. XVIII (1972).
J.A. Brighton, W.S. Pierce, D.Landis & G. Rosenberg, Measuring Cardiac Output of Pneumatically Driven Total Artificial Hearts, published in 30th Anniversary Conference on Engineering in Medicine and Biology: Proceedings, vol. 19 (Nov. 5-9, 1977).
Operator's Instructions, Fresenius 90/2 Peritoneal Therapy Cycler (Rev. C. copyright 1991-2000).
Memorandum of Donald X. Vaccarino entitled 90/2 History File (1991-1992).
Document entitled 90/2 Cycler Software, Version 3.96 (Jan. 24, 1992).
Software Change Requests (Jul. 8, 1991-Oct. 3, 1992).
Brochure entitled Fresenius Delivers 90/2 Peritoneal Therapy Cycler (Apr. 2001).
90/2 Cycler Parts List (Nov. 6, 1997).
90/2 Brochure (Jul. 1993).
Training aid entitled Learning to Use the Inpersol Cycler 3000, dated Jul. 1991.
Fresenius Freedom Cycler Operating Instructions.
Opening Expert Witness Report of Dr. Juan Santiago Regarding Anticipation and Obviousness of the Claims of U.S. Pat. Nos. 6,503,062 and 6,808,369 in view of the Prior Art and based on the Indefiniteness, Lack of Enablement, and Lack of Written Description of Certain Claims of U.S. Pat. Nos. 6,503,062 and 6,808,369, Apr. 24, 2009.
Opening Expert Witness Report of William K. Durfee Regarding whether Certain Claims of U.S. Pat. No. 5,324,422, U.S. Pat. No. 5,421,823, U.S. Pat. No. 5,431,626 and U.S. Pat. No. 5,438,510 were Ready for Patenting, Apr. 24, 2009.
Expert Witness Report of Fred K. Forster: Analysis of Obviousness of Certain Asserted Claims of U.S. Pat. Nos. 5,431,626; 5,324,422; and 5,438,510, Apr. 24, 2009.
Expert Witness Report of Ronald J. Adrian Regarding Lack of Written Description, Lack of Enablement, and Indefiniteness of the Asserted Claim (Claim 12) of U.S. Pat. No. 6,814,547, Apr. 24, 2009.
Exhibit A, Credentials of Ronald J. Adrian.
Exhibit B, Materials Considered by Ronald J. Adrian.
Expert Report on Development of the PD700 and Motivation to Combine the PD700 and U.S. Pat. No. 5,088,515, Sven Olofsson, Apr. 24, 2009.
Expert Witness Report of Juan G. Santiago Regarding Lack of Written Description, Non-Enablement, and Indefiniteness of the Asserted Claims of U.S. Pat. Nos. 5,421,823; 5,324,422; 5,438,510; and 5,431,626, Apr. 24, 2009.
Opening Expert Witness Report of Dr. Martin Roberts Regarding a History of Peritoneal Dialysis and the Obviousness and Consequent Invalidity of the Asserted Claims of U.S. Pat. No. 5,421,823, Apr. 24, 2009.
Opening Expert Witness Report of Dr. Darrell Long Regarding Technical Features of the High Flow Peritoneal Dialysis and Personal Cycler Machines, Apr. 24, 2009.
Non-final Office Action for U.S. Appl. No. 11/617,527 dated Nov. 24, 2008.
Final Office Action for U.S. Appl. No. 11/617,527 dated May 5, 2009.
Non-final Office Action for U.S. Appl. No. 11/617,527 dated Aug. 12, 2009.
Non-final Office Action for U.S. Appl. No. 11/614,850 dated May 14, 2009.
Non-Final Office Action for U.S. Appl. No. 10/155,754 dated Sep. 11, 2003.
Final Office Action for U.S. Appl. No. 10/155,754 dated Mar. 24, 2004.
Final Office Action for U.S. Appl. No. 11/614,850 dated Mar. 18, 2010.
Non-Final Office Action for U.S. Appl. No. 11/614,858 dated May 13, 2010.
Final Office Action for U.S. Appl. No. 11/617,527 dated Jan. 21, 2010.
Non-Final Office Action for U.S. Appl. No. 11/617,527 dated Jul. 16, 2010.
Non-Final Office Action for U.S. Appl. No. 10/446,068 dated May 12, 2006.
Final Office Action for U.S. Appl. No. 10/446,068 dated Nov. 7, 2006.
Non-Final Office Action for U.S. Appl. No. 10/446,068 dated Sep. 7, 2007.
Final Office Action for U.S. Appl. No. 10/446,068 dated Feb. 28, 2008.
Final Office Action for U.S. Appl. No. 10/446,068 dated Jul. 31, 2008.
Non-Final Office Action for U.S. Appl. No. 10/446,068 dated Nov. 14, 2008.
Non-Final Office Action for U.S. Appl. No. 11/773,787 dated Jul. 28, 2010.
Non-Final Office Action for U.S. Appl. No. 12/506,738 dated Jun. 24, 2011.
Non-Final Office Action for U.S. Appl. No. 12/903,902 dated Jul. 6, 2011.
Non-Final Office Action for U.S. Appl. No. 12/903,887 dated Jul. 6, 2011.
Non-Final Office Action for U.S. Appl. No. 11/773,148 dated May 17, 2010.
Final Office Action for U.S. Appl. No. 11/773,148 dated Feb. 7, 2011.
Non-Final Office Action for U.S. Appl. No. 12/408,432 dated Mar. 3, 2011.
Non-Final Office Action for U.S. Appl. No. 12/987,738 dated Apr. 29, 2011.
Sleep-safeTM Technical Manual, Part No. 6778071, 2nd edition, Dec. 2001.
Defendants' L.P.R. 2.3 Initial Non-Infringement and Invalidity Contentions (w/Exhibits).
Defendants' L.P.R. 2.1 Final Invalidity Contentions.
Exhibit 1 to Defendants' L.P.R. 3.1 Final Invalidity Contentions.
Exhibit 2 to Defendants' L.P.R. 3.1. Final Invalidity Contentions.
Exhibit 3 to Defendants' L.P.R. 3.1. Final Invalidity Contentions.
Exhibit 4 to Defendants' L.P.R. 3.1. Final Invalidity Contentions.
Appendix B: Pericycle Product and References Describing the Pericycle in Combinations with Other Prior Art References.
Appendix G: Bilstad and Kruger References Together or in Combination with Other Prior Art References.
Appendix H: Combination of 90/2 and Bilstad Together, or in Combination with Other References.
Appendix I: French Patent Nos. 2,371,931 and 2,240,740 in Combination with Other Prior Art References.
Fresenius Medical Care Slide Presentation for sleep-safeTM.
Sleep-safeTM Brochure.
Fresenius Medical Care Operating Instructions for sleep-safeTM, Software Version 1.0, Part No. 677 805 1.
Fresenius Medical Care Technical Manual for sleep-safeTM, Part No. 677 807 1.
Fresenius Medical Care Acute Dialysis Machine Operating Instructions for acu-men, Software Version 1.0.
Ronco et al., “Evolution of Machines for Automated Peritoneal Dialysis”, Technical Aspects and Solutions for ADP, 1999, pp. 142-161, vol. 129.
Related Publications (1)
Number Date Country
20170014566 A1 Jan 2017 US
Divisions (1)
Number Date Country
Parent 10078568 Feb 2002 US
Child 10446068 US
Continuations (4)
Number Date Country
Parent 13685358 Nov 2012 US
Child 15280543 US
Parent 11617543 Dec 2006 US
Child 13685358 US
Parent 10446068 May 2003 US
Child 11617543 US
Parent 09501778 Feb 2000 US
Child 10078568 US